CMBI Lowers Price Target for SUNNY OPTICAL (02382.HK) to HKD91.38, Retains Buy Rating
Profit Forecast for 2025: SUNNY OPTICAL anticipates a net profit increase of 70-75% year-on-year for 2025, driven by high-end product upgrades and investment income from a deal with Goertek Optical Tech.
Future Revenue Drivers: The company is expected to benefit from trends in smart driving, AI/AR glasses production, and high-end camera upgrades in 2026, which may counterbalance challenges in the smartphone sector.
EPS Forecast Adjustments: CMBI has revised its earnings per share forecasts for SUNNY OPTICAL for 2026 and 2027 down by 1-4% due to anticipated difficulties in the smartphone industry.
Target Price Update: The target price for SUNNY OPTICAL shares has been lowered from HKD101.47 to HKD91.38, although the Buy rating remains unchanged.
Trade with 70% Backtested Accuracy
Analyst Views on 02382
About the author

Morgan Stanley's Market Strategy: The report highlights new additions to the focus list for Hong Kong and Chinese markets, including GIGADEVICE and SINOPEC CORP, while removing SUNNY OPTICAL and ESPRESSIF.
Stock Performance: Notable stock movements include SINOPEC CORP and CHALCO showing gains, while GIGADEVICE and SUNNY OPTICAL experienced declines, with significant short selling activity reported across various stocks.
Stock Performance Overview: Various stocks are showing mixed performance, with Alibaba (BABA.US) up by 17.8% and CHALCO (601600.SH) increasing by 20.7%, while others like DUALITYBIO-B (09606.HK) and NARI (600406.SH) are experiencing slight declines.
Short Selling Activity: Significant short selling is noted in several stocks, including Tencent (00700.HK) with $1.04B and a ratio of 13.981%, indicating investor skepticism about these stocks.
Earnings Reports: HKEX (00388.HK) has posted strong earnings last quarter, maintaining an "Overweight" rating from JPM, suggesting positive investor sentiment.
Market Trends: The overall market shows a mix of gains and losses, with some stocks like SUNNY OPTICAL (02382.HK) and PING AN (02318.HK) experiencing modest increases amidst varying short selling ratios.

Market Performance: The Hang Seng Index (HSI) fell by 242 points (0.9%) to 27,023, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 1.7% and 1.0%, respectively.
Active Heavyweights: Major stocks like Meituan, Tencent, Alibaba, and Xiaomi saw significant drops, with Meituan down 4.2% and Tencent down 2.6%, amidst high short selling activity.
Notable Movers: Wuxi AppTec and Wuxi Bio both hit new highs, increasing by 3.9% and 3.7%, respectively, while Bud APAC and Trip.com saw declines of 5% and 4.3%.
Short Selling Trends: High short selling ratios were observed across various stocks, with NetEase Music experiencing the largest drop of 11.9%, while Fit Hon Teng and COSCO Ship Energy saw substantial gains of over 10%.
Morgan Stanley's Strategy Report: The report highlights a focus on Hong Kong and Chinese stocks, removing YANGTZE POWER and adding CHALCO to the list.
Stock Performance Insights: Notable potential upside percentages are reported for various stocks, including Alibaba (3.3%) and CATL (43.3%), while some stocks like ESPRESSIF show a decline (-2.498%).
Short Selling Trends: Significant short selling activity is noted across several stocks, with Tencent experiencing the highest short selling amount at $1.59 billion and a ratio of 9.036%.
Market Outlook: Daiwa anticipates a structural recovery in Chinese stocks by 2025, despite a majority of consumers expecting profit deterioration.

Market Performance: The Chinese stock market saw a rebound in January, with the HSI/ MSCI China Index increasing by 6.9% and 5% MoM, despite a significant sell-off by the 'National Team' amounting to US$68 billion.
Top Performers: WUXI BIO and PLOVER BAY TECH were highlighted as top performers with returns of 17.7% and 16.6%, respectively, while several stocks, including Alibaba and Ganfeng Lithium, were added to the Buy list.
Volatility Outlook: UOB Kay Hian anticipates continued market volatility in February due to recent corrections in gold and silver prices, but maintains a positive medium-term outlook supported by macro policies.
Stock Recommendations: The broker updated its recommendations, adding stocks like Alibaba and Ganfeng Lithium to the Buy list, while placing Meituan on the Sell list, and noted the need to cut losses on several other stocks.

Profit Forecast for 2025: SUNNY OPTICAL anticipates a net profit increase of 70-75% year-on-year for 2025, driven by high-end product upgrades and investment income from a deal with Goertek Optical Tech.
Future Revenue Drivers: The company is expected to benefit from trends in smart driving, AI/AR glasses production, and high-end camera upgrades in 2026, which may counterbalance challenges in the smartphone sector.
EPS Forecast Adjustments: CMBI has revised its earnings per share forecasts for SUNNY OPTICAL for 2026 and 2027 down by 1-4% due to anticipated difficulties in the smartphone industry.
Target Price Update: The target price for SUNNY OPTICAL shares has been lowered from HKD101.47 to HKD91.38, although the Buy rating remains unchanged.






